4.8 Article

IL-34 Actions on FOXP3+Tregs and CD14+Monocytes Control Human Graft Rejection

期刊

FRONTIERS IN IMMUNOLOGY
卷 11, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.01496

关键词

IL-34; transplantation; tolerance; monocyte; Treg; cell therapy; GVHD; CSF-1R

资金

  1. Labex IGO program - National Research Agency via the investment of the future program [ANR-11-LABX-0016-01]
  2. French Government [ANR-10-IBHU005]
  3. Nantes Metropole
  4. Pays de la Loire Region
  5. Agence Nationale de la Recherche [ANR-17-CE18-0008]
  6. Fondation du rein Don de Soi - Don de Vie 2017 FdR-Trans-Forme/FRM
  7. Agence de la Biomedecine

向作者/读者索取更多资源

Cytokines are major players regulating immune responses toward inflammatory and tolerogenic results. In organ and bone marrow transplantation, new reagents are needed to inhibit tissue destructive mechanisms and eventually induce immune tolerance without overall immunosuppression. IL-34 is a cytokine with no significant homology with any other cytokine but that acts preferentially through CSF-1R, as CSF-1 does, and through PTP zeta and CD138. Although IL-34 and CSF-1 share actions, a detailed analysis of their effects on immune cells needs further research. We previously showed that both CD4(+)and CD8(+)FOXP3(+)Tregs suppress effector T cells through the production of IL-34, but not CSF-1, and that this action was mediated through antigen-presenting cells. We showed here by single-cell RNAseq and cytofluorimetry that different subsets of human monocytes expressed different levels of CSF-1R, CD138, and PTP zeta and that both CD4(+)and CD8(+)FOXP3(+)Tregs expressed higher levels of CSF-1R than conventional T cells. The effects of IL-34 differed in the survival of these different subpopulations of monocytes and RNAseq analysis showed several genes differentially expressed between IL-34, CSF-1, M0, M1, and also M2 macrophages. Acute graft-vs.-host disease (aGVHD) in immunodeficient NSG mice injected with human PBMCs was decreased when treated with IL-34 in combination with an anti-CD45RC mAb that depleted conventional T cells. When IL-34-differentiated monocytes were used to expand Tregsin vitro, both CD4(+)and CD8(+)FOXP3(+)Tregs were highly enriched and this effect was superior to the one obtained with CSF-1. Human CD8(+)Tregs expandedin vitrowith IL-34-differentiated allogeneic monocytes suppressed human immune responses in an NSG mouse aGVHD model humanized with hPBMCs. Overall, we showed that IL-34 induced the differentiation of human monocytes with a particular transcriptional profile and these cells favored the development of potent suppressor FOXP3(+)Tregs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据